Limitations, agreements, and source contact

Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma · Source last updated 2017-07-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

hearn.jay.cho@med.nyu.edu

organization

NYU Cancer Institute

phone

212-263-9274

title

Hearn J. Cho, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice